Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 • 1,655 citations
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
1989 • 1,411 citations
NF-κB as a Therapeutic Target in Multiple Myeloma
2002 • 906 citations
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
2002 • 759 citations
Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
1996 • 582 citations
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
2003 • 572 citations
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
2001 • 562 citations
Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma
2001 • 492 citations
Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications
2002 • 467 citations
Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
1993 • 437 citations
Molecular mechanisms of novel therapeutic approaches for multiple myeloma
2002 • 431 citations
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
2001 • 420 citations
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
1997 • 416 citations
The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applications
2001 • 398 citations
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma
2002 • 302 citations
Interleukin-6 Inhibits Apoptosis of Malignant Plasma Cells
1995 • 287 citations
Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells
1997 • 278 citations
IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathway
1999 • 249 citations
Cytochrome c-dependent and -independent Induction of Apoptosis in Multiple Myeloma Cells
1997 • 200 citations
SHP2 Mediates the Protective Effect of Interleukin-6 against Dexamethasone-induced Apoptosis in Multiple Myeloma Cells
2000 • 189 citations
Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
1997 • 174 citations
The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway
2001 • 171 citations
Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells
1999 • 157 citations
Activation of Fes Tyrosine Kinase by gp130, an Interleukin-6 Family Cytokine Signal Transducer, and Their Association
1995 • 147 citations
Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1
2000 • 133 citations
Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
1994 • 131 citations
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
2002 • 120 citations
RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells
1999 • 119 citations
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998 • 85 citations
Activation of the Signal Transducer Glycoprotein 130 by Both IL-6 and IL-11 Requires Two Distinct Binding Epitopes
1999 • 79 citations
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
2000 • 68 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 66 citations
Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells.
1995 • 56 citations
Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol
2002 • 50 citations
The gp 130 family cytokines IL‐6, LIF and OSM but not IL‐11 can reverse the anti‐proliferative effect of dexamethasone on human myeloma cells
1995 • 46 citations
Interleukin-6-Induced Tyrosine Phosphorylation of Multiple Proteins in Murine Hematopoietic Lineage Cells
1994 • 37 citations
Interleukin-6 prevents dexamethasone-induced myeloma cell death
1994 • 32 citations
Cited By (0)
No citing papers found in database